Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Frontiers in Aging Neuroscience
|
April 4, 2022
COVCOG 1: Factors Predicting Physical, Neurological and Cognitive Symptoms in Long COVID in a Community Sample. A First Publication From the COVID and Cognition Study
Panyuan Guo, Alvaro Benito Ballesteros, Sabine P Yeung, et al.
Journal of Child and Adolescent Psychopharmacology
|
July 12, 2023
Cariprazine in Pediatric Patients with Autism Spectrum Disorder: Results of a Pharmacokinetic, Safety and Tolerability Study
Paul P Yeung, Kimball A Johnson, Robert Riesenberg, et al.
Headache
|
April 23, 2021
Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study
Richard B Lipton, Joshua M Cohen, Maja Galic, et al.
Cephalalgia : an International Journal of Headache
|
April 19, 2018
A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects
Orit Cohen-Barak, Sivan Weiss, Michele Rasamoelisolo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 27, 2004
Quetiapine improves psychotic symptoms and cognition in Parkinson's disease
Jorge L Juncos, Vicki J Roberts, Marian L Evatt, et al.
The New England Journal of Medicine
|
November 25, 2017
Fremanezumab for the Preventive Treatment of Chronic Migraine
Stephen D Silberstein, David W Dodick, Marcelo E Bigal, et al.
JAMA
|
May 26, 2018
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial
David W Dodick, Stephen D Silberstein, Marcelo E Bigal, et al.
New Zealand Veterinary Journal
|
February 12, 2025
Investigating animals and environments in contact with leptospirosis patients in Aotearoa New Zealand reveals complex exposure pathways
J Benschop, J M Collins-Emerson, E Vallee, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 24, 2005
Inter-relationships between DNA damage, ascorbic acid and glycaemic control in Type 2 diabetes mellitus
S W Choi, I F F Benzie, C S Y Lam, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 10, 2016
A multicentre demonstration project to evaluate the effectiveness and acceptability of the web-based Joint Asia Diabetes Evaluation (JADE) programme with or without nurse support in Chinese patients with Type 2 diabetes
G E Tutino, W Y Yang, X Li, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Frontiers in Aging Neuroscience
|
April 4, 2022
COVCOG 1: Factors Predicting Physical, Neurological and Cognitive Symptoms in Long COVID in a Community Sample. A First Publication From the COVID and Cognition Study
Panyuan Guo, Alvaro Benito Ballesteros, Sabine P Yeung, et al.
Journal of Child and Adolescent Psychopharmacology
|
July 12, 2023
Cariprazine in Pediatric Patients with Autism Spectrum Disorder: Results of a Pharmacokinetic, Safety and Tolerability Study
Paul P Yeung, Kimball A Johnson, Robert Riesenberg, et al.
Headache
|
April 23, 2021
Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study
Richard B Lipton, Joshua M Cohen, Maja Galic, et al.
Cephalalgia : an International Journal of Headache
|
April 19, 2018
A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects
Orit Cohen-Barak, Sivan Weiss, Michele Rasamoelisolo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 27, 2004
Quetiapine improves psychotic symptoms and cognition in Parkinson's disease
Jorge L Juncos, Vicki J Roberts, Marian L Evatt, et al.
The New England Journal of Medicine
|
November 25, 2017
Fremanezumab for the Preventive Treatment of Chronic Migraine
Stephen D Silberstein, David W Dodick, Marcelo E Bigal, et al.
JAMA
|
May 26, 2018
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial
David W Dodick, Stephen D Silberstein, Marcelo E Bigal, et al.
New Zealand Veterinary Journal
|
February 12, 2025
Investigating animals and environments in contact with leptospirosis patients in Aotearoa New Zealand reveals complex exposure pathways
J Benschop, J M Collins-Emerson, E Vallee, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 24, 2005
Inter-relationships between DNA damage, ascorbic acid and glycaemic control in Type 2 diabetes mellitus
S W Choi, I F F Benzie, C S Y Lam, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 10, 2016
A multicentre demonstration project to evaluate the effectiveness and acceptability of the web-based Joint Asia Diabetes Evaluation (JADE) programme with or without nurse support in Chinese patients with Type 2 diabetes
G E Tutino, W Y Yang, X Li, et al.
Page
of 9